---

Registration has closed.

---

Date & Time of CTFG

Date:   23 May 2018
Time:  12:15pm - 19:00pm (CTFG is open to public)

---

Location

Matrix Building, Level 4
Creation Theatrette
30 Biopolis Street
Singapore 138671

---

Programme

 

Time
11.30 – 12.15	SCSS AGM 2018 (Restricted to SCSS members only!)
12.15 – 13.00	Lunch Networking
13.00– 13.15	Welcome & Introduction to CTFG Launch Ray DUNN & John DANGERFIELD (Open to public)
13.15-14.55	Session 1 (Chair: Shigeki SUGII, Singapore Bioimaging Consortium)
13.15- 13.40	Glycosaminoglycans as Adjuvants for Enhanced Cellular Therapy Simon COOL, Institute of Medical Biology, Singapore
13.40 – 14.05	Growing and Using Blood Stem Cells: Already a Reality William HWANG, Singapore General Hospital
14.05 – 14.30	A Co-operative Framework for Encouraging Responsible Innovation with Autologous Cellular Therapies Tamra LYSAGHT, National University of Singapore
14:30 – 14:55	The Next Generation of T Cell Therapy to Tackle the Solid Tumor Challenge John CONNOLLY, TESSA Therapeutics, Singapore
14.55 – 15.30	Tea break

 

15.30 – 16:45	Session 2 (Chair: John DANGERFIELD, AustriaNova, Singapore)
15.30 – 15.55	TCR-T Cell Product Development Strategy from Lab to Market Lietao Victor LI, Lion TCR, Singapore
15.55 – 16.20	An Overview of Cell-based Therapy in Malaysia Angela NG, Universiti Kebangsaan Malaysia Medical Centre, Malaysia
16.20 – 16.45	Clinical Outcomes of Mesenchymal Stem Cell (MSC) Therapy for Cartilage Regeneration in Singapore James HUI, National University Health System, Singapore
16:45 – 16:50	Announcement: Duke-NUS, BioLamina and Novo Nordisk enter collaborative research on stem cell-based therapy for heart and eye diseases Karl Tryggvason, Duke-NUS, Singapore
16:50 – 17:30	Panel Discussion Fostering Translational Research (Moderators: Tamra LYSAGHT & Ray DUNN) Panel members: James Hui, Simon Cool, John Connolly
17.30 – 19:00	Wine & Dinner networking

 

---

More information about the speakers

---

Registration has closed.

---